Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MYLAN

  • FDA Approval
  • Feb. 22, 2023, 12:39 UTC
  • 28
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; SPIRONOLACTONE

Comment Full text

GLAXOSMITHKLINE CONS

  • FDA Approval
  • Feb. 22, 2023, 12:39 UTC
  • 28
  • 0 comments

FDA approve DICLOFENAC SODIUM

Comment Full text

GLAXOSMITHKLINE

  • FDA Approval
  • Feb. 22, 2023, 12:39 UTC
  • 26
  • 0 comments

FDA approve DIPHENHYDRAMINE CITRATE; IBUPROFEN

Comment Full text

CHEPLAPHARM

  • FDA Approval
  • Feb. 22, 2023, 12:39 UTC
  • 27
  • 0 comments

FDA approve TRETINOIN

Comment Full text

SAGENT PHARMS INC

  • FDA Approval
  • Feb. 22, 2023, 12:39 UTC
  • 26
  • 0 comments

FDA approve NEOSTIGMINE METHYLSULFATE

Comment Full text

TEVA PHARMS

  • FDA Approval
  • Feb. 22, 2023, 12:39 UTC
  • 29
  • 0 comments

FDA approve DOXEPIN HYDROCHLORIDE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Feb. 22, 2023, 12:39 UTC
  • 28
  • 0 comments

FDA approve SIROLIMUS

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • Feb. 22, 2023, 12:39 UTC
  • 28
  • 0 comments

FDA approve FLUVASTATIN SODIUM

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • Feb. 22, 2023, 03:25 UTC
  • 27
  • 0 comments

FDA approve CANAGLIFLOZIN;METFORMIN HYDROCHLORIDE

Comment Full text

GLENMARK PHARMS

  • FDA Approval
  • Feb. 22, 2023, 03:09 UTC
  • 29
  • 0 comments

FDA approve SAXAGLIPTIN

Comment Full text
  • Previous
  • 877
  • 878
  • 879
  • 880
  • 881
  • Next

Search

News categories

  • Technical Exchange News(12226)
  • Event(6176)
  • SEC News(263580)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(154486)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin